These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25275834)

  • 1. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.
    Pitre-Champagnat S; Leguerney I; Bosq J; Peronneau P; Kiessling F; Calmels L; Coulot J; Lassau N
    Invest Radiol; 2015 Apr; 50(4):212-7. PubMed ID: 25275834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography.
    Lavisse S; Lejeune P; Rouffiac V; Elie N; Bribes E; Demers B; Vrignaud P; Bissery MC; Brulé A; Koscielny S; Péronneau P; Lassau N
    Invest Radiol; 2008 Feb; 43(2):100-11. PubMed ID: 18197062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.
    Zhou JH; Zheng W; Cao LH; Liu M; Luo RZ; Han F; Wu PH; Li AH
    Eur J Radiol; 2012 Jun; 81(6):1360-5. PubMed ID: 21345633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves.
    Gauthier TP; Chebil M; Peronneau P; Lassau N
    Ultrasonics; 2012 Jan; 52(1):12-9. PubMed ID: 21722933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.
    Kim J; Kim JH; Yoon SH; Choi WS; Kim YJ; Han JK; Choi BI
    Ultrasound Med Biol; 2015 Dec; 41(12):3131-9. PubMed ID: 26365926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
    Wang H; Hristov D; Qin J; Tian L; Willmann JK
    Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.
    Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH
    Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study.
    Gauthier M; Tabarout F; Leguerney I; Polrot M; Pitre S; Peronneau P; Lassau N
    J Ultrasound Med; 2012 Apr; 31(4):595-608. PubMed ID: 22441917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiplicative model for improving microvascular flow estimation in dynamic contrast-enhanced ultrasound (DCE-US): theory and experimental validation.
    Barrois G; Coron A; Payen T; Dizeux A; Bridal L
    IEEE Trans Ultrason Ferroelectr Freq Control; 2013 Nov; 60(11):2284-94. PubMed ID: 24158285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography.
    Lassau N; Coiffier B; Faivre L; Benatsou B; Bidault S; Girard E; Asselain B; Pitre-Champagnat S; Koscielny S
    Invest Radiol; 2017 Mar; 52(3):148-154. PubMed ID: 28106614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of angiogenesis in rabbit orthotropic liver tumors using three-dimensional dynamic contrast-enhanced ultrasound compared with two-dimensional DCE-US.
    Zheng Q; Zhang JC; Wang Z; Ruan SM; Li W; Pan FS; Chen LD; Zhang YC; Wu WX; Xie XY; Lu MD; Shan QY; Wang W
    Jpn J Radiol; 2019 Oct; 37(10):701-709. PubMed ID: 31401722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.
    Peronneau P; Lassau N; Leguerney I; Roche A; Cosgrove D
    Ultraschall Med; 2010 Aug; 31(4):370-8. PubMed ID: 20577941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
    Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
    Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma.
    Zhuo J; Fu W; Liu S
    Ultraschall Med; 2014 Oct; 35(5):468-72. PubMed ID: 24327471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors.
    Wan CF; Du J; Fang H; Li FH; Zhu JS; Liu Q
    Radiology; 2012 Feb; 262(2):450-9. PubMed ID: 22282183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.
    Lassau N; Bonastre J; Kind M; Vilgrain V; Lacroix J; Cuinet M; Taieb S; Aziza R; Sarran A; Labbe-Devilliers C; Gallix B; Lucidarme O; Ptak Y; Rocher L; Caquot LM; Chagnon S; Marion D; Luciani A; Feutray S; Uzan-Augui J; Coiffier B; Benastou B; Koscielny S
    Invest Radiol; 2014 Dec; 49(12):794-800. PubMed ID: 24991866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype.
    Cao M; Liang Y; Shen C; Miller KD; Stantz KM
    IEEE Trans Med Imaging; 2009 Jun; 28(6):861-71. PubMed ID: 19150783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.